0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chip-based Oligonucleotide Synthesis Market Size, Status and Forecast 2026-2032
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-15M20016
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Chip based Oligonucleotide Synthesis Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Chip-based Oligonucleotide Synthesis Market Size, Status and Forecast 2026-2032

Code: QYRE-Auto-15M20016
Report
2026-02-03
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chip-based Oligonucleotide Synthesis Market Size

The global Chip-based Oligonucleotide Synthesis market was valued at US$ 49.71 million in 2025 and is anticipated to reach US$ 215 million by 2032, at a CAGR of 23.6% from 2026 to 2032.

Chip-based Oligonucleotide Synthesis Market

Chip-based Oligonucleotide Synthesis Market

Chip-based oligonucleotide synthesis is a high-throughput, cost-effective method utilizing microarray chips to mass-produce short DNA or RNA fragments. Compared to traditional synthesis methods, this technology offers faster speed, higher precision, and greater flexibility, making it especially suitable for fields like gene editing, synthetic biology, and genome sequencing. By enabling parallel synthesis, researchers can simultaneously produce thousands to millions of different oligonucleotide sequences on a single chip, significantly improving experimental efficiency and data output, thereby accelerating research and applications in the life sciences.
The North American market for Chip-based Oligonucleotide Synthesis is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Chip-based Oligonucleotide Synthesis is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Chip-based Oligonucleotide Synthesis in Scientific Research is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Chip-based Oligonucleotide Synthesis include Thermo Fisher, GenScript, LC Sciences, Twist Bioscience, Agilent Technologies, Evonetix, Dynegene Technologies, LC-Bio Technologies, Atantares, BGI Genomics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report focuses on the global Chip-based Oligonucleotide Synthesis status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Chip-based Oligonucleotide Synthesis development in different regions.
It segments the global Chip-based Oligonucleotide Synthesis market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Chip-based Oligonucleotide Synthesis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Chip-based Oligonucleotide Synthesis Market Report

Report Metric Details
Report Name Chip-based Oligonucleotide Synthesis Market
Accounted market size in 2025 US$ 49.71 million
Forecasted market size in 2032 US$ 215 million
CAGR 23.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Photochemical Method
  • Electrochemical Method
  • Inkjet Printing Method
Segment by Application
  • Scientific Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher, GenScript, LC Sciences, Twist Bioscience, Agilent Technologies, Evonetix, Dynegene Technologies, LC-Bio Technologies, Atantares, BGI Genomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Chip-based Oligonucleotide Synthesis Market growing?

Ans: The Chip-based Oligonucleotide Synthesis Market witnessing a CAGR of 23.6% during the forecast period 2026-2032.

What is the Chip-based Oligonucleotide Synthesis Market size in 2032?

Ans: The Chip-based Oligonucleotide Synthesis Market size in 2032 will be US$ 215 million.

Who are the main players in the Chip-based Oligonucleotide Synthesis Market report?

Ans: The main players in the Chip-based Oligonucleotide Synthesis Market are Thermo Fisher, GenScript, LC Sciences, Twist Bioscience, Agilent Technologies, Evonetix, Dynegene Technologies, LC-Bio Technologies, Atantares, BGI Genomics

What are the Application segmentation covered in the Chip-based Oligonucleotide Synthesis Market report?

Ans: The Applications covered in the Chip-based Oligonucleotide Synthesis Market report are Scientific Research, Others

What are the Type segmentation covered in the Chip-based Oligonucleotide Synthesis Market report?

Ans: The Types covered in the Chip-based Oligonucleotide Synthesis Market report are Photochemical Method, Electrochemical Method, Inkjet Printing Method

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chip-based Oligonucleotide Synthesis Market Size Growth Rate by Type (2026-2032)
1.2.2 Photochemical Method
1.2.3 Electrochemical Method
1.2.4 Inkjet Printing Method
1.3 Market by Application
1.3.1 Global Chip-based Oligonucleotide Synthesis Market Share by Application (2026-2032)
1.3.2 Scientific Research
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chip-based Oligonucleotide Synthesis Market Size
2.2 Chip-based Oligonucleotide Synthesis Market Size by Region
2.2.1 Chip-based Oligonucleotide Synthesis Growth Rate by Region (2026-2032)
2.2.2 Chip-based Oligonucleotide Synthesis Market Share by Region (2026-2032)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Chip-based Oligonucleotide Synthesis Revenue by Players (2026 & 2032)
3.2 Chip-based Oligonucleotide Synthesis Key Players Headquarters and Area Served
3.3 Key Players Chip-based Oligonucleotide Synthesis Product/Solution/Service
3.4 Date of Enter into Chip-based Oligonucleotide Synthesis Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and Application
4.1 Global Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032)
4.2 Global Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032)
5 North America
5.1 North America Chip-based Oligonucleotide Synthesis Market Forecast (2026-2032)
5.2 Chip-based Oligonucleotide Synthesis Key Players in North America
5.3 North America Chip-based Oligonucleotide Synthesis Market Size by Type
5.4 North America Chip-based Oligonucleotide Synthesis Market Size by Application
6 Europe
6.1 Europe Chip-based Oligonucleotide Synthesis Market Forecast (2026-2032)
6.2 Chip-based Oligonucleotide Synthesis Key Players in Europe
6.3 Europe Chip-based Oligonucleotide Synthesis Market Size by Type
6.4 Europe Chip-based Oligonucleotide Synthesis Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Chip-based Oligonucleotide Synthesis Market Forecast (2026-2032)
7.2 Chip-based Oligonucleotide Synthesis Key Players in Asia-Pacific
7.3 Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size by Type
7.4 Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size by Application
8 Rest of World
8.1 Latin America
8.1.1 Latin America Chip-based Oligonucleotide Synthesis Market Analysis
8.1.2 Key Players in Latin America
8.2 Middle East & Africa
8.2.1 Middle East & Africa Chip-based Oligonucleotide Synthesis Market Analysis
8.2.2 Key Players in Middle East & Africa
9 International Players Profiles
9.1 Thermo Fisher
9.1.1 Thermo Fisher Company Details
9.1.2 Thermo Fisher Description and Business Overview
9.1.3 Thermo Fisher Chip-based Oligonucleotide Synthesis Introduction
9.1.4 Thermo Fisher Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.1.5 Thermo Fisher Recent Development
9.2 GenScript
9.2.1 GenScript Company Details
9.2.2 GenScript Description and Business Overview
9.2.3 GenScript Chip-based Oligonucleotide Synthesis Introduction
9.2.4 GenScript Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.2.5 GenScript Recent Development
9.3 LC Sciences
9.3.1 LC Sciences Company Details
9.3.2 LC Sciences Description and Business Overview
9.3.3 LC Sciences Chip-based Oligonucleotide Synthesis Introduction
9.3.4 LC Sciences Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.3.5 LC Sciences Recent Development
9.4 Twist Bioscience
9.4.1 Twist Bioscience Company Details
9.4.2 Twist Bioscience Description and Business Overview
9.4.3 Twist Bioscience Chip-based Oligonucleotide Synthesis Introduction
9.4.4 Twist Bioscience Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.4.5 Twist Bioscience Recent Development
9.5 Agilent Technologies
9.5.1 Agilent Technologies Company Details
9.5.2 Agilent Technologies Description and Business Overview
9.5.3 Agilent Technologies Chip-based Oligonucleotide Synthesis Introduction
9.5.4 Agilent Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.5.5 Agilent Technologies Recent Development
9.6 Evonetix
9.6.1 Evonetix Company Details
9.6.2 Evonetix Description and Business Overview
9.6.3 Evonetix Chip-based Oligonucleotide Synthesis Introduction
9.6.4 Evonetix Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.6.5 Evonetix Recent Development
9.7 Dynegene Technologies
9.7.1 Dynegene Technologies Company Details
9.7.2 Dynegene Technologies Description and Business Overview
9.7.3 Dynegene Technologies Chip-based Oligonucleotide Synthesis Introduction
9.7.4 Dynegene Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.7.5 Dynegene Technologies Recent Development
9.8 LC-Bio Technologies
9.8.1 LC-Bio Technologies Company Details
9.8.2 LC-Bio Technologies Description and Business Overview
9.8.3 LC-Bio Technologies Chip-based Oligonucleotide Synthesis Introduction
9.8.4 LC-Bio Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.8.5 LC-Bio Technologies Recent Development
9.9 Atantares
9.9.1 Atantares Company Details
9.9.2 Atantares Description and Business Overview
9.9.3 Atantares Chip-based Oligonucleotide Synthesis Introduction
9.9.4 Atantares Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.9.5 Atantares Recent Development
9.10 BGI Genomics
9.10.1 BGI Genomics Company Details
9.10.2 BGI Genomics Description and Business Overview
9.10.3 BGI Genomics Chip-based Oligonucleotide Synthesis Introduction
9.10.4 BGI Genomics Revenue in Chip-based Oligonucleotide Synthesis Business (2026 & 2032)
9.10.5 BGI Genomics Recent Development
10 Chip-based Oligonucleotide Synthesis Market Dynamics
10.1 Chip-based Oligonucleotide Synthesis Industry Trends
10.2 Chip-based Oligonucleotide Synthesis Market Drivers
10.3 Chip-based Oligonucleotide Synthesis Market Challenges
10.4 Chip-based Oligonucleotide Synthesis Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details
List of Tables
 Table 1. Global Chip-based Oligonucleotide Synthesis Market Size Growth Rate by Type (2026-2032) & (US$ Million)
 Table 2. Key Players of Photochemical Method
 Table 3. Key Players of Electrochemical Method
 Table 4. Key Players of Inkjet Printing Method
 Table 5. Global Chip-based Oligonucleotide Synthesis Market Size Growth by Application (2026-2032) & (US$ Million)
 Table 6. Global Chip-based Oligonucleotide Synthesis Market Size by Region (2026-2032) & (US$ Million)
 Table 7. Global Chip-based Oligonucleotide Synthesis Market Size by Region (2026-2032) & (US$ Million)
 Table 8. Global Chip-based Oligonucleotide Synthesis Market Share by Region (2026-2032)
 Table 9. Market Top Trends
 Table 10. Market Use Cases
 Table 11. Global Chip-based Oligonucleotide Synthesis Revenue by Players (2026 & 2032) & (US$ Million)
 Table 12. Global Chip-based Oligonucleotide Synthesis Market Share by Players (2026 & 2032)
 Table 13. Key Players Headquarters and Area Served
 Table 14. Key Players Chip-based Oligonucleotide Synthesis Product/Solution/Service
 Table 15. Date of Enter into Chip-based Oligonucleotide Synthesis Market
 Table 16. Mergers & Acquisitions, Expansion Plans
 Table 17. Global Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032) & (US$ Million)
 Table 18. Global Chip-based Oligonucleotide Synthesis Market Size Share by Type (2026-2032)
 Table 19. Global Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032) & (US$ Million)
 Table 20. Global Chip-based Oligonucleotide Synthesis Market Size Share by Application (2026-2032)
 Table 21. North America Key Players Chip-based Oligonucleotide Synthesis Revenue (2026 & 2032) & (US$ Million)
 Table 22. North America Key Players Chip-based Oligonucleotide Synthesis Market Share (2026 & 2032)
 Table 23. North America Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032) & (US$ Million)
 Table 24. North America Chip-based Oligonucleotide Synthesis Market Share by Type (2026-2032)
 Table 25. North America Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032) & (US$ Million)
 Table 26. North America Chip-based Oligonucleotide Synthesis Market Share by Application (2026-2032)
 Table 27. Europe Key Players Chip-based Oligonucleotide Synthesis Revenue (2026 & 2032) & (US$ Million)
 Table 28. Europe Key Players Chip-based Oligonucleotide Synthesis Market Share (2026 & 2032)
 Table 29. Europe Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032) & (US$ Million)
 Table 30. Europe Chip-based Oligonucleotide Synthesis Market Share by Type (2026-2032)
 Table 31. Europe Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032) & (US$ Million)
 Table 32. Europe Chip-based Oligonucleotide Synthesis Market Share by Application (2026-2032)
 Table 33. Asia-Pacific Key Players Chip-based Oligonucleotide Synthesis Revenue (2026 & 2032) & (US$ Million)
 Table 34. Asia-Pacific Key Players Chip-based Oligonucleotide Synthesis Market Share (2026 & 2032)
 Table 35. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size by Type (2026-2032) & (US$ Million)
 Table 36. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Share by Type (2026-2032)
 Table 37. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size by Application (2026-2032) & (US$ Million)
 Table 38. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Share by Application (2026-2032)
 Table 39. Key Players in Latin America
 Table 40. Key Players in Middle East & Africa
 Table 41. Thermo Fisher Company Details
 Table 42. Thermo Fisher Description and Business Overview
 Table 43. Thermo Fisher Chip-based Oligonucleotide Synthesis Product
 Table 44. Thermo Fisher Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 45. Thermo Fisher Recent Development
 Table 46. GenScript Company Details
 Table 47. GenScript Description and Business Overview
 Table 48. GenScript Chip-based Oligonucleotide Synthesis Product
 Table 49. GenScript Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 50. GenScript Recent Development
 Table 51. LC Sciences Company Details
 Table 52. LC Sciences Description and Business Overview
 Table 53. LC Sciences Chip-based Oligonucleotide Synthesis Product
 Table 54. LC Sciences Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 55. LC Sciences Recent Development
 Table 56. Twist Bioscience Company Details
 Table 57. Twist Bioscience Description and Business Overview
 Table 58. Twist Bioscience Chip-based Oligonucleotide Synthesis Product
 Table 59. Twist Bioscience Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 60. Twist Bioscience Recent Development
 Table 61. Agilent Technologies Company Details
 Table 62. Agilent Technologies Description and Business Overview
 Table 63. Agilent Technologies Chip-based Oligonucleotide Synthesis Product
 Table 64. Agilent Technologies Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 65. Agilent Technologies Recent Development
 Table 66. Evonetix Company Details
 Table 67. Evonetix Description and Business Overview
 Table 68. Evonetix Chip-based Oligonucleotide Synthesis Product
 Table 69. Evonetix Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 70. Evonetix Recent Development
 Table 71. Dynegene Technologies Company Details
 Table 72. Dynegene Technologies Description and Business Overview
 Table 73. Dynegene Technologies Chip-based Oligonucleotide Synthesis Product
 Table 74. Dynegene Technologies Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 75. Dynegene Technologies Recent Development
 Table 76. LC-Bio Technologies Company Details
 Table 77. LC-Bio Technologies Description and Business Overview
 Table 78. LC-Bio Technologies Chip-based Oligonucleotide Synthesis Product
 Table 79. LC-Bio Technologies Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 80. LC-Bio Technologies Recent Development
 Table 81. Atantares Company Details
 Table 82. Atantares Description and Business Overview
 Table 83. Atantares Chip-based Oligonucleotide Synthesis Product
 Table 84. Atantares Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 85. Atantares Recent Development
 Table 86. BGI Genomics Company Details
 Table 87. BGI Genomics Description and Business Overview
 Table 88. BGI Genomics Chip-based Oligonucleotide Synthesis Product
 Table 89. BGI Genomics Revenue in Chip-based Oligonucleotide Synthesis Business: 2026 & 2032
 Table 90. BGI Genomics Recent Development
 Table 91. Chip-based Oligonucleotide Synthesis Market Trends
 Table 92. Chip-based Oligonucleotide Synthesis Market Drivers
 Table 93. Chip-based Oligonucleotide Synthesis Market Challenges
 Table 94. Chip-based Oligonucleotide Synthesis Market Restraints
 Table 95. Research Programs/Design for This Report
 Table 96. Key Data Information from Secondary Sources
 Table 97. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Chip-based Oligonucleotide Synthesis Market Share by Type in 2026 & 2032
 Figure 2. Photochemical Method Features
 Figure 3. Electrochemical Method Features
 Figure 4. Inkjet Printing Method Features
 Figure 5. Global Chip-based Oligonucleotide Synthesis Market Share by Application in 2026 & 2032
 Figure 6. Scientific Research Case Studies
 Figure 7. Others Case Studies
 Figure 8. Chip-based Oligonucleotide Synthesis Report Years Considered
 Figure 9. Global Chip-based Oligonucleotide Synthesis Market Size and Growth Rate 2026-2032 (US$ Million)
 Figure 10. Global Chip-based Oligonucleotide Synthesis Market Share by Region (2026-2032)
 Figure 11. Global Chip-based Oligonucleotide Synthesis Market Size Market Share by Type (2026-2032)
 Figure 12. North America Chip-based Oligonucleotide Synthesis Market Size 2026-2032 (US$ Million)
 Figure 13. Europe Chip-based Oligonucleotide Synthesis Market Size 2026-2032 (US$ Million)
 Figure 14. Asia-Pacific Chip-based Oligonucleotide Synthesis Market Size 2026-2032 (US$ Million)
 Figure 15. Chip-based Oligonucleotide Synthesis Market Size in Latin America (2026-2032) & (US$ Million)
 Figure 16. Chip-based Oligonucleotide Synthesis Market Size in Middle East & Africa (2026-2032) & (US$ Million)
 Figure 17. Bottom-up and Top-down Approaches for This Report
 Figure 18. Data Triangulation
 Figure 19. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS